Michael Karbiener

12PUBLICATIONS
14CO-AUTHORS
Wastewater treatment processesOenology and viticultureInnate immunityCharacterisation of biological macromoleculesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 07, 2026
Design Space Assessment of Virus Inactivation in Plasma-Derived Matrices Establishes a Single Detergent Alternative to TX-100-Containing Mixes.

|Oct 03, 2024
Parvovirus B19 rebound outbreak 2024 and implications for blood- and plasma-product safety.

Maria R Farcet, Michael Karbiener, Claudia Aberham

|Jun 17, 2024
Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.

Michael Karbiener, Gerhard Kindle, Isabelle Meyts

|Apr 09, 2024
Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins.

Min-Hsin Chen, Ludmila Perelygina, LiJuan Hao

|May 13, 2023
Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC.

Jean-Baptiste Farcet, Michael Karbiener, Leonhard Zelger

|Sep 23, 2022
Orthopox viruses and the safety margins of solvent-detergent treated plasma-derived medicinal products.

Johanna Kindermann, Michael Karbiener, Thomas R Kreil

Pageof 2

Frequent Collaborators

9 joint publications

Thomas R Kreil

3 joint publications

Maria R Farcet

2 joint publications

Jean-Baptiste Farcet

1 joint publications

Markus Gugatschka